Related references
Note: Only part of the references are listed.N′[4-(dipropylamino)benzylidene]-2-hydroxybenzohydrazide is a dynamin GTPase inhibitor that suppresses cancer cell migration and invasion by inhibiting actin polymerization
Hiroshi Yamada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma
Hans-Georg Wirsching et al.
BRAIN (2014)
Thymosin Beta-4 Knockdown in IEC-6 Normal Intestinal Epithelial Cells Induces DNA Re-replication Via Downregulating Emi1
Ta-Chung Chao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Small-Molecule Intramimics of Formin Autoinhibition: A New Strategy to Target the Cytoskeletal Remodeling Machinery in Cancer Cells
L. Leanne Lash et al.
CANCER RESEARCH (2013)
A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells
A. D. Kim et al.
CELL DEATH & DISEASE (2013)
Thymosin β4: A Potential Molecular Target for Tumor Therapy
Yongtao Xiao et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration
Yun-Kyoung Ryu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma
Zhi Yu Wang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Thymosin β4 knockdown disrupts mitochondrial functions of SW480 human colon cancer cells
Mei-Chuan Tang et al.
CANCER SCIENCE (2011)
Membrane Translocation of Binary Actin-ADP-Ribosylating Toxins from Clostridium difficile and Clostridium perfringens Is Facilitated by Cyclophilin A and Hsp90
Eva Kaiser et al.
INFECTION AND IMMUNITY (2011)
Thymosin β4 targeting impairs tumorigenic activity of colon cancer stem cells
Lucia Ricci-Vitiani et al.
FASEB JOURNAL (2010)
Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1α stabilization in HeLa human cervical tumor cells
Jin-Mi Oh et al.
LIFE SCIENCES (2010)
Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase
H.-C. Huang et al.
ONCOGENE (2007)
Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death
Eun-Yi Moon et al.
ONCOLOGY RESEARCH (2007)
ERK activation by Thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance
Su-Young Oh et al.
EXPERIMENTAL CELL RESEARCH (2006)
Overexpression of thymosin β-4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively
HL Hsiao et al.
CARCINOGENESIS (2006)
Overexpression of the thymosin β-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma
WS Wang et al.
ONCOGENE (2004)
Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
I Bock-Marquette et al.
NATURE (2004)
Role of thymosin β4 in tumor metastasis and angiogenesis
HJ Cha et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Overexpression of the thymosin β-4 gene is associated with malignant progression of SW480 colon cancer cells
WS Wang et al.
ONCOGENE (2003)
Thymosin beta(4) and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice
D Philp et al.
WOUND REPAIR AND REGENERATION (2003)
Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells
AM Otto et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo
G Sosne et al.
EXPERIMENTAL EYE RESEARCH (2001)